» Articles » PMID: 26458308

High Cytoplasmic Expression of SALL4 Predicts A malignant Phenotype and Poor Prognosis of Breast Invasive Ductal Carcinoma

Overview
Journal Neoplasma
Specialty Oncology
Date 2015 Oct 14
PMID 26458308
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Sal-like 4(SALL4) is significant for maintaining self-renewal and pluripotency in embryonic stem cells, cancer cells and perhaps even cancer stem cells. The expression of SALL4 has been recorded in various kinds of cancers and is deemed to have a clinical value for diagnosis. However, little information on SALL4 expression has been illustrated in breast cancer. In this study, the expression of SALL4 was scrutinized by immunohistochemical analysis in breast invasive ductal carcinoma in a large cohort of 160 patients. High cytoplasmic expression of SALL4 was detected in breast cancer tissues compared with normal adjacent tissues. High SALL4 expression was associated with advanced tumor invasion (p = 0.019), lymph node stage (p = 0.027), ER (p = 0.030), PR (p = 0.037), HER2 (p = 0.019) and TNBC (p = 0.007) in overall patients. Interestingly, in Kaplan-Meier analysis, breast cancer patients with high expression of SALL4 demonstrated a worse OS. Both univariate and multivariate analysis illustrated that examination of SALL4 was of great prognostic value in OS. Thus, our data showed that high cytoplasmic expression of SALL4 was considered to be an independent prognostic indicator for breast invasive ductal carcinoma.

Citing Articles

Cytoplasmic SALL4-A isoform expression as a diagnostic marker of less aggressive tumor behavior in gastric cancer.

Rahmani S, Babajani A, Abolhasani M, Ghods R, Kalantari E, Madjd Z World J Surg Oncol. 2025; 23(1):41.

PMID: 39905414 PMC: 11796022. DOI: 10.1186/s12957-025-03681-w.


Expression of stem cell markers SALL4, LIN28A, and KLF4 in ameloblastoma.

de Albuquerque Dias R, Balbinot K, da Silva Kataoka M, de Melo Alves Junior S, de Jesus Viana Pinheiro J Diagn Pathol. 2023; 18(1):92.

PMID: 37559082 PMC: 10413759. DOI: 10.1186/s13000-023-01379-9.


The new advance of SALL4 in cancer: Function, regulation, and implication.

Abouelnazar F, Zhang X, Wang M, Zhang J, Yu D, Zang X J Clin Lab Anal. 2023; 37(9-10):e24927.

PMID: 37337914 PMC: 10388233. DOI: 10.1002/jcla.24927.


Dual-Regulated Mechanism of EZH2 and KDM6A on SALL4 Modulates Tumor Progression via Wnt/β-Catenin Pathway in Gastric Cancer.

Ren L, Deng H, Jiang Y, Liu C Dig Dis Sci. 2023; 68(4):1292-1305.

PMID: 36877334 DOI: 10.1007/s10620-022-07790-4.


Role of SALL4 in HER2+ Breast Cancer Progression: Regulating PI3K/AKT Pathway.

Pattanayak B, Lameirinhas A, Torres-Ruiz S, Burgues O, Rovira A, Martinez M Int J Mol Sci. 2022; 23(21).

PMID: 36362083 PMC: 9655635. DOI: 10.3390/ijms232113292.